HSA — authorised 24 April 2024
- Marketing authorisation holder: ALEMBIC THERAP
- Status: likely_approved
🇸🇬 Pivamdinocillin in Singapore
HSA authorised Pivamdinocillin on 24 April 2024
Marketing authorisation
Pivamdinocillin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Singapore
Frequently asked questions
Is Pivamdinocillin approved in Singapore?
Yes. HSA authorised it on 24 April 2024.
Who is the marketing authorisation holder for Pivamdinocillin in Singapore?
ALEMBIC THERAP holds the Singaporean marketing authorisation.